From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

I don’t drink to my acknowledgement that I was wrong about Diageo!

By Chris Bailey of Financial Orbit | Saturday 29 January 2022


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


You should never mind a bit of hindsight from the 0.001% of people who did something a bit bonkers and made a fortune. I guess I should have theoretically invested a couple of thousand quid in bitcoin eight or ten years ago and would now look like a genius.  Whilst I am sure there are a few people who have made themselves absolute fortunes this way, I reckon 99% of people who did buy a few bitcoin back then, probably did not make much money (even if they could log into their electronic link successfully). Famously I sold my ASOS (ASC) shares a gazillion years ago after doubling my money, which was not very smart from the perspective of where the shares ended up fifteen years or so later. I am still living and learning 26 years into my actual investment life.  And that brings me back to Diageo (DGE) which had its latest numbers last Thursday…

Premium content is for paid subscribers only
ShareProphets is reader-supported journalism

Become a member starting at £6.99 per month for all articles, the Bearcast, and our seven year archive.


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

 

AAU

Gold up Ariana down

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 07:48:37